Influence of subinhibitory concentrations of brodimoprim and trimethoprim on the adhesiveness, hydrophobicity, hemagglutination and motility of escherichia coli

P. C. Braga, M. Dal Sasso, S. Maci, S. Reggio, G. Piatti

Research output: Contribution to journalArticle

Abstract

In the present study the ability of subinhibitory concentrations (sub-MICs) of brodimoprim (a new 2,4-dimethoxybenzylpyri-midine) to interfere with some important aspects of bacterial cell function, such as surface hydrophobicity, fimbriation, motility and adhesiveness to mucosal cells, was investigated in comparison with those of trimethoprim. The inhibitory behavior of both diaminopyrimidines concerning hydrophobicity and hemagglutination (fimbriation) were essentially the same, while for adhesiveness and motility brodimoprim was more effective than trimethoprim. Diaminopyrimidines have high affinity for the bacterial enzyme dihydrofolate reductase, and this reduces the synthesis of essential purines and as a conse-quence of DNA and proteins. Our findings indicate that the synthesis and/or the expression of surface adhesins, which are proteins, was also affected by both brodimoprim and trimethoprim, the former being more active.

Original languageEnglish
Pages (from-to)50-58
Number of pages9
JournalChemotherapy
Volume41
Issue number1
DOIs
Publication statusPublished - 1995

Fingerprint

Adhesiveness
Trimethoprim
Hemagglutination
Hydrophobic and Hydrophilic Interactions
Escherichia coli
Purines
Tetrahydrofolate Dehydrogenase
Proteins
DNA
Enzymes
brodimoprim

Keywords

  • Adhesiveness
  • Brodimoprim
  • Escherichia coli
  • Fimbriation
  • Hydrophobicity
  • Motility
  • Subinhibitory concentration
  • Trimethoprim

ASJC Scopus subject areas

  • Infectious Diseases
  • Oncology
  • Pharmacology (medical)
  • Drug Discovery
  • Pharmacology

Cite this

Influence of subinhibitory concentrations of brodimoprim and trimethoprim on the adhesiveness, hydrophobicity, hemagglutination and motility of escherichia coli. / Braga, P. C.; Sasso, M. Dal; Maci, S.; Reggio, S.; Piatti, G.

In: Chemotherapy, Vol. 41, No. 1, 1995, p. 50-58.

Research output: Contribution to journalArticle

@article{2bccf0ce372046ce8eb2b5c58180c7af,
title = "Influence of subinhibitory concentrations of brodimoprim and trimethoprim on the adhesiveness, hydrophobicity, hemagglutination and motility of escherichia coli",
abstract = "In the present study the ability of subinhibitory concentrations (sub-MICs) of brodimoprim (a new 2,4-dimethoxybenzylpyri-midine) to interfere with some important aspects of bacterial cell function, such as surface hydrophobicity, fimbriation, motility and adhesiveness to mucosal cells, was investigated in comparison with those of trimethoprim. The inhibitory behavior of both diaminopyrimidines concerning hydrophobicity and hemagglutination (fimbriation) were essentially the same, while for adhesiveness and motility brodimoprim was more effective than trimethoprim. Diaminopyrimidines have high affinity for the bacterial enzyme dihydrofolate reductase, and this reduces the synthesis of essential purines and as a conse-quence of DNA and proteins. Our findings indicate that the synthesis and/or the expression of surface adhesins, which are proteins, was also affected by both brodimoprim and trimethoprim, the former being more active.",
keywords = "Adhesiveness, Brodimoprim, Escherichia coli, Fimbriation, Hydrophobicity, Motility, Subinhibitory concentration, Trimethoprim",
author = "Braga, {P. C.} and Sasso, {M. Dal} and S. Maci and S. Reggio and G. Piatti",
year = "1995",
doi = "10.1159/000239324",
language = "English",
volume = "41",
pages = "50--58",
journal = "Chemotherapy",
issn = "0009-3157",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Influence of subinhibitory concentrations of brodimoprim and trimethoprim on the adhesiveness, hydrophobicity, hemagglutination and motility of escherichia coli

AU - Braga, P. C.

AU - Sasso, M. Dal

AU - Maci, S.

AU - Reggio, S.

AU - Piatti, G.

PY - 1995

Y1 - 1995

N2 - In the present study the ability of subinhibitory concentrations (sub-MICs) of brodimoprim (a new 2,4-dimethoxybenzylpyri-midine) to interfere with some important aspects of bacterial cell function, such as surface hydrophobicity, fimbriation, motility and adhesiveness to mucosal cells, was investigated in comparison with those of trimethoprim. The inhibitory behavior of both diaminopyrimidines concerning hydrophobicity and hemagglutination (fimbriation) were essentially the same, while for adhesiveness and motility brodimoprim was more effective than trimethoprim. Diaminopyrimidines have high affinity for the bacterial enzyme dihydrofolate reductase, and this reduces the synthesis of essential purines and as a conse-quence of DNA and proteins. Our findings indicate that the synthesis and/or the expression of surface adhesins, which are proteins, was also affected by both brodimoprim and trimethoprim, the former being more active.

AB - In the present study the ability of subinhibitory concentrations (sub-MICs) of brodimoprim (a new 2,4-dimethoxybenzylpyri-midine) to interfere with some important aspects of bacterial cell function, such as surface hydrophobicity, fimbriation, motility and adhesiveness to mucosal cells, was investigated in comparison with those of trimethoprim. The inhibitory behavior of both diaminopyrimidines concerning hydrophobicity and hemagglutination (fimbriation) were essentially the same, while for adhesiveness and motility brodimoprim was more effective than trimethoprim. Diaminopyrimidines have high affinity for the bacterial enzyme dihydrofolate reductase, and this reduces the synthesis of essential purines and as a conse-quence of DNA and proteins. Our findings indicate that the synthesis and/or the expression of surface adhesins, which are proteins, was also affected by both brodimoprim and trimethoprim, the former being more active.

KW - Adhesiveness

KW - Brodimoprim

KW - Escherichia coli

KW - Fimbriation

KW - Hydrophobicity

KW - Motility

KW - Subinhibitory concentration

KW - Trimethoprim

UR - http://www.scopus.com/inward/record.url?scp=0028942031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028942031&partnerID=8YFLogxK

U2 - 10.1159/000239324

DO - 10.1159/000239324

M3 - Article

C2 - 7875023

AN - SCOPUS:0028942031

VL - 41

SP - 50

EP - 58

JO - Chemotherapy

JF - Chemotherapy

SN - 0009-3157

IS - 1

ER -